This upcoming NIH grant will fund multidisciplinary research to better understand joint pain, improve joint health, and develop new treatments by advancing mapping, profiling, and modeling of joint tissues and pain mechanisms.
NIH supports milestone-driven development of non-addictive small molecule and biologic pain treatments, from lead optimization through Phase I testing, to prepare candidates for Phase II trials.
This grant supports interdisciplinary research to understand how non-addictive natural products manage chronic pain through holistic, multisystem approaches, aiming to develop safe, evidence-based pain relief strategies.
Funding for research developing non-addictive pain treatments through early drug discovery to support the Pain Therapeutics Development Program.
This grant supports short-term exploratory clinical trials to improve prevention, diagnosis, or treatment of arthritis, musculoskeletal, or skin diseases through early-stage research.
NIH seeks a single center to coordinate research, build capacity, assess barriers, and develop resources supporting integrated care for chronic pain and opioid use disorder; clinical trials are not allowed.